Lattice degeneration of the retina is a condition in which the retinal pigment epithelium (RPE) begins to deteriorate, leading to the formation of small, yellowish spots along the retina. This condition can cause vision loss, as the spots may block light from entering the eye. It is most commonly seen in people over the age of 40, but can affect younger people as well. In this article, we will explore the causes and consequences of lattice degeneration of the retina and discuss how doctors can help patients manage the condition.
Lattice degeneration of the retina is a condition in which the retinal pigment epithelium (RPE) begins to deteriorate, leading to the formation of small, yellowish spots along the retina. These spots are known as lattice degenerations, and they can cause vision loss if they block light from entering the eye. The condition is most common in people over the age of 40, but it can affect younger people as well.
The exact cause of lattice degeneration of the retina is unknown, but it is believed to be related to aging. As people age, the retinal pigment epithelium (RPE) begins to break down, leading to the formation of lattice degenerations. Other factors that may contribute to the condition include genetics, trauma to the eye, and certain medications or diseases.
There are certain risk factors that can increase a person’s likelihood of developing lattice degeneration of the retina. These include age, genetics, trauma to the eye, certain medications or diseases, and a family history of the condition. Additionally, people with diabetes or high blood pressure may be at an increased risk for the condition.
Lattice degeneration of the retina can be diagnosed through a comprehensive eye exam. During the exam, the doctor will use a special instrument called an ophthalmoscope to examine the back of the eye. The doctor will be looking for the characteristic yellowish spots that are associated with the condition. In some cases, imaging tests such as an OCT (optical coherence tomography) scan may be used to confirm the diagnosis.
In most cases, treatment for lattice degeneration of the retina is not necessary. The condition is usually asymptomatic and does not cause any vision loss. However, if the condition does cause vision loss, the doctor may recommend certain treatments such as laser surgery or anti-VEGF (vascular endothelial growth factor) injections. These treatments can help to reduce the size of the lattice degenerations and improve vision.
Unfortunately, there is no sure way to prevent lattice degeneration of the retina. However, there are certain steps that can be taken to reduce the risk of developing the condition. These include getting regular eye exams, eating a healthy diet, exercising regularly, and avoiding smoking and excessive alcohol consumption. Additionally, people with diabetes or high blood pressure should be sure to keep their condition under control.
Lattice degeneration of the retina is a condition that affects many people over the age of 40. It is caused by the deterioration of the retinal pigment epithelium, leading to the formation of small, yellowish spots along the retina. The condition can cause vision loss if it blocks light from entering the eye. While there is no sure way to prevent the condition, doctors can help patients manage it by recommending certain treatments and lifestyle changes.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation